Page last updated: 2024-08-22

ruthenium and 1,2-dioleoyloxy-3-(trimethylammonium)propane

ruthenium has been researched along with 1,2-dioleoyloxy-3-(trimethylammonium)propane in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
D'Errico, G; Irace, C; Mangiapia, G; Montesarchio, D; Musumeci, D; Paduano, L; Santamaria, R; Vitiello, G1
Cadavid-Vargas, JF; Di Virgilio, AL; Etcheverry, SB; Leon, IE1
Capuozzo, A; Caraglia, M; D'Errico, G; Ferraro, MG; Irace, C; Maione, F; Misso, G; Montesarchio, D; Paduano, L; Piccolo, M; Riccardi, C; Santamaria, R; Stiuso, P; Trifuoggi, M; Zarone, MR1
Campanella, A; Del Vecchio, P; Montesarchio, D; Oliva, R; Paduano, L; Riccardi, C1
Bocchetti, M; Ferraro, MG; Irace, C; Misso, G; Montesarchio, D; Paduano, L; Piccolo, M; Riccardi, C; Santamaria, R; Trifuoggi, M1

Reviews

1 review(s) available for ruthenium and 1,2-dioleoyloxy-3-(trimethylammonium)propane

ArticleYear
Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.
    Current medicinal chemistry, 2017, Volume: 24, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Coordination Complexes; Copper; Drug Carriers; Fatty Acids, Monounsaturated; Humans; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Porphyrins; Quaternary Ammonium Compounds; Ruthenium; Vanadium

2017

Other Studies

4 other study(ies) available for ruthenium and 1,2-dioleoyloxy-3-(trimethylammonium)propane

ArticleYear
A new design for nucleolipid-based Ru(III) complexes as anticancer agents.
    Dalton transactions (Cambridge, England : 2003), 2013, Dec-28, Volume: 42, Issue:48

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Coordination Complexes; Drug Design; Fatty Acids, Monounsaturated; Humans; Neoplasms; Phosphatidylcholines; Quaternary Ammonium Compounds; Ruthenium; Uridine

2013
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer.
    Scientific reports, 2019, 05-07, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Agents; Autophagy; Autophagy-Related Proteins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Fatty Acids, Monounsaturated; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Molecular Structure; Nanoparticles; Quaternary Ammonium Compounds; Ruthenium; Xenograft Model Antitumor Assays

2019
Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study.
    Molecules (Basel, Switzerland), 2023, Mar-20, Volume: 28, Issue:6

    Topics: Antineoplastic Agents; Blood Proteins; Coordination Complexes; Humans; Liposomes; Organometallic Compounds; Ruthenium

2023
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem.
    International journal of molecular sciences, 2023, Mar-30, Volume: 24, Issue:7

    Topics: Antineoplastic Agents; Cell Line, Tumor; Fatty Acids, Monounsaturated; Female; Humans; Liposomes; Ruthenium; Triple Negative Breast Neoplasms

2023